Skip to content
Review

The Potential Role and Mechanism of RBM47-Mediated Genes in Atherosclerosis

Jul 2026 · DNA and Cell Biology · Vol 45, pp. 480 - 489 · 0 citations · 80 references
Medicine

TL;DR

The role of RBM47 in other genes that contain AREs and GREs, such as apoA-II, ABCA1, HMGCR, IFN-γ, IL-15, low-density lipoprotein receptor, oxidized low-density lipoprotein receptor 1, and programmed cell death 1 ligand 1, is unclear is unclear.

Abstract

RNA-binding motif 47 (RBM47), a hub gene in atherosclerosis, induced oxidative stress in macrophages in atherosclerosis progression by enhancing ENC1 stability via binding to the AU-rich elements (AREs). However, RBM47 promoted C-to-U editing of multiple genes, such as acyl-CoA synthetase family member 2 (ACSF2), apoB, CD36, CD170, IL-10, oxysterol binding protein like 9, and transmembrane protein 30a (TMEM30A). These genes play important roles in atherosclerosis. Thus, the role of RBM47 in atherosclerosis may be complex. Notably, ACSF2 and HECT and RLD domain containing E3 ubiquitin protein ligase 2 promoted ferroptosis. TMEM30A exhibited a “don’t eat me” signal. CD170 decreased ADAMTS13 activity. Recombinant ADAMTS-13 was undergoing phase 3 clinical trials. However, the biological significance of these genes after RNA editing, except for apoB and tight junction protein 1, is unclear. RBM47 also stabilized Axin1, Cullin 3, IL-8, Dickkopf WNT signaling pathway inhibitor 1, Kelch-like ECH-associated protein 1, and IL-10 expression by recognizing the GAUSAW (S = G/C, W = A/U) motif and AREs/GU-rich elements (GREs). However, the role of RBM47 in other genes that contain AREs and GREs, such as apoA-II, ABCA1, HMGCR, IFN-γ, IL-15, low-density lipoprotein receptor, oxidized low-density lipoprotein receptor 1, and programmed cell death 1 ligand 1, is unclear. This review focuses on the role and mechanism of RBM47-mediated genes in atherosclerosis to provide knowledge for new targets.

View source

Similar papers

Review Open access Jul 2026

The Molecular Structure, Expression, and Emerging Role of the 15-Leucine-Rich Repeat Containing Membrane Protein (LRRC15) in Skeletal Biology and Diseases

Understanding the role of LRRC15 in the bone, joint and tumor microenvironment will facilitate the development of new therapeutic options—particularly LRRC15-based target therapies—for skeletal diseases.

Zi-Hao Lin, Zhi-Chao Hu, Chang-Qing Zhang et al. · 0 citations
Open access Aug 2026

ABTB1, as an E3 ubiquitin ligase, suppresses Th17 cell differentiation and mitigates autoimmune inflammation by promoting STAT3 ubiquitination and degradation

The research demonstrates the critical role of ABTB1 in regulating the differentiation and function of Th17 cells under conditions of autoimmune diseases and may represent a potential therapeutic target for inflammatory bowel disease (IBD) and other autoimmune disorders.

Fei Xu, Shuang Zhao, Yan Jiang et al. · 0 citations
Review Open access Jul 2026

The emerging role of ZDHHC9 in cancer: from protein palmitoylation to tumor progression and immune regulation

The molecular basis of ZDHHC9 is summarized, its roles in tumor progression and immune regulation, and current advances and challenges in therapeutic targeting are discussed to support the development of new biomarkers and precision anticancer strategies.

Yi Fu, Ming Ma, Hai-guang Zhao et al. · 0 citations
Review Open access Jul 2026

Role of PCSK9 in hallmarks of cancer: From mechanisms to interventions (Review)

The present review elaborated on the mechanisms by which PCSK9 contributes to several hallmarks of cancer, including sustained proliferative signaling, invasion and metastasis, metabolic reprogramming, angiogenesis and tumor immune evasion through the modulation of specific substrates.

Lijuan Tang, Shu Yao, Yongheng Zhu et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.